Skip to content

Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System

A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01059357
Acronym
TORS
Enrollment
58
Registered
2010-01-29
Start date
2010-06-30
Completion date
2014-10-31
Last updated
2018-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Neoplasms

Brief summary

The purpose of this study is to conduct a pilot single-arm to assess transoral robotic surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the Da Vinci Robotic Surgical System.

Detailed description

Patients are going to be evaluated in their usual regular clinical follow ups starting with preoperative first visit, 3 weeks, 3 months and 6 months postoperatively with a Quality of Life survey (Head and Neck Cancer Inventory, HNCI-QOLQ).

Interventions

DEVICEDa Vinci Robotic Transoral Robotic Surgical System

(TORS) Da Vinci Robotic Transoral Robotic Surgical System

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient must present with indications for diagnostic or therapeutic approaches for benign and malignant diseases of the oral cavity or laryngopharynx (including the neoplastic lesions of the tongue, tongue base, retromolar trigone, tonsils, palate, posterior and lateral pharynx, glottic, supraglottic and subglottic larynx) * Patients must have adequate transoral exposure of the oral cavity and laryngopharynx for TORS instrumentation

Exclusion criteria

* Unexplained fever and/or untreated, active infection * Patient pregnancy * Previous head and neck surgery precluding transoral/robotic procedures * The presence of medical conditions contraindicating general anesthesia or transoral surgical approaches

Design outcomes

Primary

MeasureTime frameDescription
The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis.At time of surgery, lasting up to 3 hours. Assessed for up to 6 monthsIn order to evaluate the feasibility of TORS, the investigators will report the number and percent of all evaluable patients who have successfully undergone TORS at each interim analysis

Secondary

MeasureTime frameDescription
Operative TimeAt time of surgery, up to 3 hoursThe total operative times include the induction of and emergence from anesthesia, the TORS procedure, plus any adjunct procedures (eg, neck dissections) performed during the same operation.
Number of Participants With Blood Loss and Complications6 months
Average Time to Set up and Perform ProceduresAt time of surgery, up to 3 hoursThis outcome is to identify the learning curve for TORS by measuring the efficiency of the surgeon who performs the procedures.
Number of Correctly Predicted Success of TORS PreoperativelypreoperativeThis outcome is to identify the learning curve for TORS by measuring the accuracy of the surgeon who performs the procedures.
QOL6 monthsQuality of life (QOL) of the patients undergoing TORS will be measures. The score range is 0-100 with higher scores denoting better outcome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Transoral Robotic Surgery (TORS)
Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System
58
Total58

Baseline characteristics

CharacteristicTransoral Robotic Surgery (TORS)
Age, Continuous51.64 years
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
43 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 54
other
Total, other adverse events
7 / 54
serious
Total, serious adverse events
0 / 54

Outcome results

Primary

The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis.

In order to evaluate the feasibility of TORS, the investigators will report the number and percent of all evaluable patients who have successfully undergone TORS at each interim analysis

Time frame: At time of surgery, lasting up to 3 hours. Assessed for up to 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Transoral Robotic Surgery (TORS)The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis.54 Participants
Secondary

Average Time to Set up and Perform Procedures

This outcome is to identify the learning curve for TORS by measuring the efficiency of the surgeon who performs the procedures.

Time frame: At time of surgery, up to 3 hours

ArmMeasureValue (MEAN)Dispersion
Transoral Robotic Surgery (TORS)Average Time to Set up and Perform Procedures109 minutesStandard Deviation 47.1
Secondary

Number of Correctly Predicted Success of TORS Preoperatively

This outcome is to identify the learning curve for TORS by measuring the accuracy of the surgeon who performs the procedures.

Time frame: preoperative

ArmMeasureValue (NUMBER)
Transoral Robotic Surgery (TORS)Number of Correctly Predicted Success of TORS Preoperatively53 procedures
Secondary

Number of Participants With Blood Loss and Complications

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Transoral Robotic Surgery (TORS)Number of Participants With Blood Loss and Complications7 Participants
Secondary

Operative Time

The total operative times include the induction of and emergence from anesthesia, the TORS procedure, plus any adjunct procedures (eg, neck dissections) performed during the same operation.

Time frame: At time of surgery, up to 3 hours

ArmMeasureValue (MEAN)Dispersion
Transoral Robotic Surgery (TORS)Operative Time321 minutesStandard Deviation 136.63
Secondary

QOL

Quality of life (QOL) of the patients undergoing TORS will be measures. The score range is 0-100 with higher scores denoting better outcome.

Time frame: 6 months

Population: Data not collected on all participants

ArmMeasureValue (MEAN)Dispersion
Transoral Robotic Surgery (TORS)QOL52 score on a scaleStandard Deviation 13.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026